Table 2.
Follow-up details of the study population, including unadjusted mortality rates, by GN subtype
| GN Subtype | No. of Patients (%) | Person Time at Risk, y | No. of Deaths (%) | Mortality Rate per 100 Person Years (95% Confidence Interval) |
|---|---|---|---|---|
| IgAN | 13,012 (15.4) | 76,901 | 2839 (21.8) | 3.69 (3.56 to 3.83) |
| FSGS | 34,330 (40.7) | 179,364 | 13,721 (40.0) | 7.65 (7.52 to 7.78) |
| LN | 16,463 (19.5) | 84,585 | 6741 (41.0) | 7.97 (7.78 to 8.16) |
| MPGN | 5193 (6.2) | 26,869 | 2405 (46.3) | 8.95 (8.59 to 9.31) |
| MN | 7177 (8.5) | 34,482 | 3382 (47.1) | 9.81 (9.48 to 10.14) |
| Vasculitis | 8126 (9.6) | 29,456 | 4686 (57.7) | 15.91 (15.45 to 16.36) |
IgAN, IgA nephropathy; LN, lupus nephritis; MPGN, membranoproliferative GN; MN, membranous nephropathy.